Neurofibromatosis Type I

Disease Overview

Neurofibromatosis Type I (NF1) is a genetic disorder characterized by the development of multiple benign tumors of nerves and skin (neurofibromas) and areas of abnormal pigmentation (café-au-lait spots). It is one of the most common neurological genetic disorders, affecting multiple body systems with variable expression and severity.

Disease Category

Genetic neurological disorder; classified as a neurocutaneous syndrome (phakomatosis) with autosomal dominant inheritance pattern.

Synonyms

Peripheral Neurofibromatosis
Recklinghausen Disease
Von Recklinghausen Neurofibromatosis

Signs & Symptoms

Primary manifestations include: - Multiple café-au-lait spots - Axillary and inguinal freckling - Lisch nodules (iris hamartomas) - Cutaneous and plexiform neurofibromas - Skeletal abnormalities (scoliosis, bone dysplasia) - Neurological complications - Cognitive and learning difficulties - Increased risk of certain cancers - Potential cardiovascular complications - Potential ophthalmological issues

Causes

Genetic mutation in the NF1 gene on chromosome 17
Mutation affects neurofibromin protein production
Disrupts cell growth regulation
50% of cases occur through spontaneous mutation
Autosomal dominant inheritance pattern

Affected Populations

Prevalence: 1 in 3,000-4,000 live births
Affects all racial and ethnic groups
Equal gender distribution
Can occur in any family background
Most cases diagnosed before age 10

Disorders with Similar Symptoms

Neurofibromatosis Type II (NF2)
Legius syndrome
Schwannomatosis
McCune-Albright syndrome
Tuberous sclerosis

Diagnosis

Diagnostic criteria include: - ≥6 café-au-lait macules - ≥2 neurofibromas - Axillary/inguinal freckling - Optic glioma - ≥2 Lisch nodules - Characteristic bone lesions - First-degree relative with NF1 - Genetic testing confirmation

Standard Therapies

Comprehensive multidisciplinary management
Regular clinical monitoring
Surgical tumor removal when necessary
Orthopedic interventions
Educational support
Psychological counseling
Symptomatic treatment
Pain management strategies

Clinical Trials and Studies

Ongoing research into:
- Targeted molecular therapies
- Cancer risk management
- Neurological intervention strategies
Clinical trials available through:
- ClinicalTrials.gov
- National Institutes of Health
- Children's Tumor Foundation

References

National Institutes of Health
Mayo Clinic
Genetics Home Reference
Children's Tumor Foundation
American Academy of Neurology

Programs & Resources

Children's Tumor Foundation
Neurofibromatosis Network
National Institute of Neurological Disorders and Stroke
National Organization for Rare Disorders
Genetic Support Foundation

Complete Report

Comprehensive medical management requires individualized approach, genetic counseling, and ongoing multidisciplinary care. Patients should consult specialized medical professionals for personalized treatment strategies.